Show simple item record

dc.contributor.authorWorld Health Organization
dc.date.accessioned2012-06-17T01:07:51Z
dc.date.available2012-06-17T01:07:51Z
dc.date.created2003fr
dc.date.issued2003fr
dc.identifier.govdocWHO/HIV/2003.10fr
dc.identifier.urihttp://www.who.int/iris/handle/10665/68673
dc.descriptionWHO/HIV/2003.10fr
dc.description1 p.fr
dc.language.isoenen
dc.language.isofren
dc.language.isoesen
dc.publisherGenève : Organisation mondiale de la Santéfr
dc.relation.ispartofseriesTreat 3 Million by 2005 Initiative technical briefsfr
dc.subject.meshHIV infectionsfr
dc.subject.meshDrug resistance, Microbialfr
dc.subject.meshAnti-retroviral agentsfr
dc.subject.otherAIDS and its Controlfr
dc.titleComment le problème de la pharmacoréistance sera-t-il abordé dans le cadre de l' initiative "3 millions d' ici 2005" ?fr
dc.subject.meshqualifierdrug therapyfr
dc.subject.meshqualifiertherapeutic usefr
who.relation.languageVersion10665/68685en
who.relation.languageVersion10665/68661en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record